Your session is about to expire
← Back to Search
Neurostimulation Device
Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System (nPower™-US Trial)
N/A
Waitlist Available
Research Sponsored by Nalu Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a small device that sends electrical signals to reduce chronic leg and back pain in adults who still have pain after back surgery. The device works by changing how pain signals are sent to the brain. This method has been shown to be effective in reducing leg and back pain, especially in patients who have not found relief from previous back surgeries.
Eligible Conditions
- Chronic Pain
- Back Pain
- Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Responders at 3-months
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nalu SCS SystemExperimental Treatment1 Intervention
All eligible subjects will receive the Nalu Neurostimulation System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nalu Neurostimulation System
2020
N/A
~110
Find a Location
Who is running the clinical trial?
Nalu Medical, Inc.Lead Sponsor
2 Previous Clinical Trials
274 Total Patients Enrolled
JIm Makous, PhDStudy DirectorNalu Medical, Inc.
Patrick MartinStudy DirectorNalu Medical
2 Previous Clinical Trials
274 Total Patients Enrolled